U01 grant from National Institutes of Health (2006-2016), PROSTANOID MODULATORS THAT REDUCE BRAIN INJURY AFTER SEIZURES

R01 grant from National Institutes of Health (2011-2015), REGULATION OF EPILEPTOGENESIS BY THE TRANSCRIPTIONAL REPRESSOR, REST

R21 grant from National Institutes of Health (2011-2013), ROLE OF COX2 OF NEURONAL ORIGIN IN BLOOD-BRAIN COMMUNICATION AFTER STATUS EPILEPTICUS

Alzheimer’s Drug Discovery Foundation (ADDF) (2013-2016), EP2 antagonists for the suppression of inflammation and neuropathology in Alzheimer's model.

Harrington Discovery Foundation (2014-2016), Formulation studies of EP2 antagonists.